Balchem (BCPC) Expected to Announce Quarterly Earnings on Friday

Balchem (NASDAQ:BCPC) is projected to issue its Q2 2025 quarterly earnings data before the market opens on Friday, July 25th. Analysts expect the company to announce earnings of $1.25 per share and revenue of $250.31 million for the quarter.

Balchem (NASDAQ:BCPC) last released its quarterly earnings data on Thursday, April 24th. The basic materials company reported $1.22 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.25 by ($0.03). Balchem had a return on equity of 12.01% and a net margin of 14.16%. The firm had revenue of $250.52 million for the quarter, compared to analyst estimates of $245.70 million. During the same quarter in the previous year, the business posted $1.03 earnings per share. Balchem’s revenue for the quarter was up 4.5% on a year-over-year basis. On average, analysts expect Balchem to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Balchem Price Performance

Balchem stock opened at $158.37 on Friday. Balchem has a 12-month low of $145.70 and a 12-month high of $186.03. The stock has a market cap of $5.17 billion, a P/E ratio of 37.98, a PEG ratio of 3.41 and a beta of 0.89. The company has a 50-day moving average price of $163.37 and a 200 day moving average price of $162.72. The company has a current ratio of 2.44, a quick ratio of 1.40 and a debt-to-equity ratio of 0.18.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of BCPC. Advisors Asset Management Inc. purchased a new position in Balchem during the first quarter worth about $27,000. Jones Financial Companies Lllp boosted its stake in Balchem by 1,768.2% during the first quarter. Jones Financial Companies Lllp now owns 822 shares of the basic materials company’s stock worth $136,000 after buying an additional 778 shares during the period. AQR Capital Management LLC boosted its stake in Balchem by 124.4% during the first quarter. AQR Capital Management LLC now owns 5,074 shares of the basic materials company’s stock worth $842,000 after buying an additional 2,813 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Balchem by 9.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 100,860 shares of the basic materials company’s stock worth $16,743,000 after buying an additional 9,118 shares during the period. Finally, Goldman Sachs Group Inc. boosted its stake in Balchem by 53.6% during the first quarter. Goldman Sachs Group Inc. now owns 246,883 shares of the basic materials company’s stock worth $40,983,000 after buying an additional 86,132 shares during the period. Hedge funds and other institutional investors own 87.91% of the company’s stock.

Wall Street Analyst Weigh In

BCPC has been the subject of several recent analyst reports. Wall Street Zen cut shares of Balchem from a “buy” rating to a “hold” rating in a research report on Wednesday, May 21st. HC Wainwright set a $180.00 price objective on shares of Balchem and gave the stock a “buy” rating in a research report on Monday, April 28th.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.